-
Mashup Score: 1Intravenous Dabigatran Provides Adequate Anticoagulation for Cardiopulmonary Bypass Using a Rabbit Model - 11 month(s) ago
The hypothesis that dabigatran would provide sufficient anticoagulation for cardiopulmonary bypass was tested in a first-use, proof-of-concept study using a rabbit model of cardiopulmonary bypass that included a comparison group receiving heparin. The dabigatran loading dose and maintenance infusions were designed after first determining its pharmacokinetics in rabbits and the target…
Categories: Anesthesiology, Latest HeadlinesTweet
-
Mashup Score: 0Dabigatran recalled over potential carcinogen - 1 year(s) ago
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet-
#Dabigatran recalled over potential #Carcinogen 👉https://t.co/0oui2bckGD @MDedgeHemOnc #AntiCoagulant #Recall https://t.co/EXLKkx4KpN
-
-
Mashup Score: 0
Parsippany. New Jersey. Ascend Laboratories LLC. is voluntarily recalling Dabigatran Etcxilate Capsules. USP 75 mg and 150 mg to the consumer/user level due to the presence of a nitrosamine. N-nitroso-dabigatran, above the established Acceptable Daily Intake (ADI) level. To date, Ascend Laboratorie
Categories: Cardiology News and Journals, Latest HeadlinesTweet-
Ascend Laboratories has announced a voluntary recall of Dabigatran (Pradaxa) Etexilate Capsules, an anticoagulant. More information: https://t.co/CllureRwnG #dabigatran #anticoagulant https://t.co/vI7tDeHdru
-
-
Mashup Score: 7Dabigatran Recalled Over Potential Carcinogen - 1 year(s) ago
Ascend Labs issues voluntary nationwide recall of dabigatran etexilate capsules (75/150 mg) after detection of unacceptable levels of a nitrosamine impurity.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Dabigatran recalled over potential carcinogen. https://t.co/SXOpAiayii #MedTwitter #drugrecall #dabigatran
-
-
Mashup Score: 0DOAC Study Finds Increased Myocardial Infarction Risk for Dabigatran | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination February 1, 2023 Ruth Jessen Hickman, MD, is a freelance medical and science writer based in Bloomington, Indiana. There are no randomized clinical trial results comparing the relative safety and efficacy of…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Among patients with #atrial #fibrillation taking #DOACS, #rivaroxaban was found to be associated with higher major bleeding rates, while #dabigatran was associated with twofold higher rates of #myocardial #infarction https://t.co/YfOtN9QdK4
-
-
Mashup Score: 1
Skip Nav Destination October 27, 2022 The direct oral anticoagulant (DOAC) dabigatran demonstrated non-inferiority to standard of care in children with thrombophilia, indicating that it could be an appropriate long-term…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
The direct oral #anticoagulant (#DOAC) #dabigatran has demonstrated non-inferiority to standard of care in children with #thrombophilia, indicating that it could be an appropriate long-term anticoagulant https://t.co/CzIwBNnZLg
-
-
Mashup Score: 2Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study - 2 year(s) ago
AbstractAims. The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding in patients with atrial fibrillation (AF) usi
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Comparison of #dabigatran #rivaroxaban, and #apixaban : a nationwide cohort study #AF https://t.co/degbjOMH3H
-
-
Mashup Score: 0Drug-induced Sweet’s syndrome likely secondary to Dabigatran - 2 year(s) ago
Megana Rao, BS Megana RaoAffiliationsIndiana University School of MedicineSahand Rahnama-Moghadam, MD, MS Sahand Rahnama-MoghadamCorrespondenceCorresponding Author: Sahand Rahnama-Moghadam MD, MS, 545 Barnhill Drive, Emerson Hall 139, Indianapolis, IN 46202. USA, (317)274-7705AffiliationsDepartment of Dermatology, Indiana University School of MedicineSearch for articles by this author This paper…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Drug- #induced #Sweet’s #syndrome likely secondary to #Dabigatran https://t.co/2gFs0loLfp
-
-
Mashup Score: 1Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation - 2 year(s) ago
Warfarin is the standard anticoagulation therapy for valvular atrial fibrillation (AF); however, new oral anticoagulants have emerged as an alternative. We compared the efficacy and safety of dabigatran with conventional treatment in AF associated with left-sided valvular heart disease (VHD), including mitral stenosis (MS). Patients with AF and left-sided VHD were randomly assigned to receive…
Source: American Journal of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
#AFib #warfarin vs #Dabigatran in #VHD https://t.co/RFTRSSGjwz
-
-
Mashup Score: 1Cognitive outcomes similar at 2 years with dabigatran vs warfarin in older adults with AF - 2 year(s) ago
In the GIRAF trial, older adults with atrial fibrillation or atrial flutter who were treated with dabigatran or warfarin had similar cognitive outcomes at 2 years, researchers reported at the American Heart Association Scientific Sessions.“Previous studies demonstrated that anticoagulation is good for the prevention of stroke, but cognitive outcomes were somehow neglected. I consider
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In the GIRAF trial, older adults with #AFib or atrial flutter who were treated with #dabigatran or #warfarin had similar cognitive outcomes at 2 years @usponline @AHAMeetings #AHA21 #CardioTwitter https://t.co/TvfNrEjRxi
-
In a first-use, proof-of-concept study, researchers using a rabbit CPB model showed that #dabigatran provides acceptable #anticoagulation similar to heparin to prevent thrombosis. Read the new article published in @_Anesthesiology: https://t.co/iFCyHjygqM https://t.co/vsIotk2Jc2